Monoclonal antibodies for detection of o
β
Georgiana Ellis; Marina Ferguson; Elaine Yamanaka; Robert B. Livingston; Allen M
π
Article
π
1989
π
John Wiley and Sons
π
English
β 645 KB
Metastases develop in 30% to 40% of patients with operable breast cancer. Investigators have reported on the detection of occult micrometastases in bone marrow using an antibody to epithelial membrane antigen (EMA) and have since reported prognostic significance for these antibody-detected cells. In